Literature DB >> 36233301

Calcium-Bound S100P Protein Is a Promiscuous Binding Partner of the Four-Helical Cytokines.

Alexey S Kazakov1, Evgenia I Deryusheva1, Maria E Permyakova1, Andrey S Sokolov1, Victoria A Rastrygina1, Vladimir N Uversky1,2, Eugene A Permyakov1, Sergei E Permyakov1.   

Abstract

S100 proteins are multifunctional calcium-binding proteins of vertebrates that act intracellularly, extracellularly, or both, and are engaged in the progression of many socially significant diseases. Their extracellular action is typically mediated by the recognition of specific receptor proteins. Recent studies indicate the ability of some S100 proteins to affect cytokine signaling through direct interaction with cytokines. S100P was shown to be the S100 protein most actively involved in interactions with some four-helical cytokines. To assess the selectivity of the S100P protein binding to four-helical cytokines, we have probed the interaction of Ca2+-bound recombinant human S100P with a panel of 32 four-helical human cytokines covering all structural families of this fold, using surface plasmon resonance spectroscopy. A total of 22 cytokines from all families of four-helical cytokines are S100P binders with the equilibrium dissociation constants, Kd, ranging from 1 nM to 3 µM (below the Kd value for the S100P complex with the V domain of its conventional receptor, receptor for advanced glycation end products, RAGE). Molecular docking and mutagenesis studies revealed the presence in the S100P molecule of a cytokine-binding site, which overlaps with the RAGE-binding site. Since S100 binding to four-helical cytokines inhibits their signaling in some cases, the revealed ability of the S100P protein to interact with ca. 71% of the four-helical cytokines indicates that S100P may serve as a poorly selective inhibitor of their action.

Entities:  

Keywords:  S100 protein; S100P; cytokine; protein–protein interaction

Mesh:

Substances:

Year:  2022        PMID: 36233301      PMCID: PMC9569990          DOI: 10.3390/ijms231912000

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  59 in total

1.  NMR structure of the Apo-S100P protein.

Authors:  Yi-Chien Lee; David E Volk; Varatharasa Thiviyanathan; Quinn Kleerekoper; Alexey V Gribenko; Shanmin Zhang; David G Gorenstein; George I Makhatadze; Bruce A Luxon
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

2.  Optimizing long intrinsic disorder predictors with protein evolutionary information.

Authors:  Kang Peng; Slobodan Vucetic; Predrag Radivojac; Celeste J Brown; A Keith Dunker; Zoran Obradovic
Journal:  J Bioinform Comput Biol       Date:  2005-02       Impact factor: 1.122

3.  Accurate prediction of disorder in protein chains with a comprehensive and empirically designed consensus.

Authors:  Xiao Fan; Lukasz Kurgan
Journal:  J Biomol Struct Dyn       Date:  2013-03-27

4.  Intrinsic disorder in S100 proteins.

Authors:  Sergei E Permyakov; Ramis G Ismailov; Bin Xue; Alexander I Denesyuk; Vladimir N Uversky; Eugene A Permyakov
Journal:  Mol Biosyst       Date:  2011-04-28

5.  Comparing and combining predictors of mostly disordered proteins.

Authors:  Christopher J Oldfield; Yugong Cheng; Marc S Cortese; Celeste J Brown; Vladimir N Uversky; A Keith Dunker
Journal:  Biochemistry       Date:  2005-02-15       Impact factor: 3.162

Review 6.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

7.  High-affinity interaction between interleukin-11 and S100P protein.

Authors:  Alexei S Kazakov; Andrei S Sokolov; Victoria A Rastrygina; Valery V Solovyev; Ramis G Ismailov; Roman V Mikhailov; Andrei B Ulitin; Andrey R Yakovenko; Tajib A Mirzabekov; Eugene A Permyakov; Sergei E Permyakov
Journal:  Biochem Biophys Res Commun       Date:  2015-11-06       Impact factor: 3.575

8.  Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins.

Authors:  Alexey S Kazakov; Alexander D Sofin; Nadezhda V Avkhacheva; Alexander I Denesyuk; Evgenia I Deryusheva; Victoria A Rastrygina; Andrey S Sokolov; Maria E Permyakova; Ekaterina A Litus; Vladimir N Uversky; Eugene A Permyakov; Sergei E Permyakov
Journal:  Int J Mol Sci       Date:  2020-12-13       Impact factor: 5.923

9.  DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation.

Authors:  Federica Quaglia; Bálint Mészáros; Edoardo Salladini; András Hatos; Rita Pancsa; Lucía B Chemes; Mátyás Pajkos; Tamas Lazar; Samuel Peña-Díaz; Jaime Santos; Veronika Ács; Nazanin Farahi; Erzsébet Fichó; Maria Cristina Aspromonte; Claudio Bassot; Anastasia Chasapi; Norman E Davey; Radoslav Davidović; Laszlo Dobson; Arne Elofsson; Gábor Erdős; Pascale Gaudet; Michelle Giglio; Juliana Glavina; Javier Iserte; Valentín Iglesias; Zsófia Kálmán; Matteo Lambrughi; Emanuela Leonardi; Sonia Longhi; Sandra Macedo-Ribeiro; Emiliano Maiani; Julia Marchetti; Cristina Marino-Buslje; Attila Mészáros; Alexander Miguel Monzon; Giovanni Minervini; Suvarna Nadendla; Juliet F Nilsson; Marian Novotný; Christos A Ouzounis; Nicolás Palopoli; Elena Papaleo; Pedro José Barbosa Pereira; Gabriele Pozzati; Vasilis J Promponas; Jordi Pujols; Alma Carolina Sanchez Rocha; Martin Salas; Luciana Rodriguez Sawicki; Eva Schad; Aditi Shenoy; Tamás Szaniszló; Konstantinos D Tsirigos; Nevena Veljkovic; Gustavo Parisi; Salvador Ventura; Zsuzsanna Dosztányi; Peter Tompa; Silvio C E Tosatto; Damiano Piovesan
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

10.  Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes-1 negatively regulates human neutrophils.

Authors:  Matevž Rumpret; Helen J von Richthofen; Maarten van der Linden; Geertje H A Westerlaken; Cami Talavera Ormeño; Teck Y Low; Huib Ovaa; Linde Meyaard
Journal:  Eur J Immunol       Date:  2021-06-19       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.